HIG1 domain family member 1A disrupts proliferation, migration, and invasion of colon adenocarcinoma cells

References

• Adamopoulos PG, Kontos CK, Rapti SM, et al. miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma. Int J Oncol. 2015;46(2):849–859.
   PubMed Web of Science ®Google Scholar
• Thanikachalam K, Khan G. Colorectal cancer and nutrition. Nutrients. 2019;11(1):164.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Lam AK, Ong K, Giv MJ, et al. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types. Pathology. 2008;40(6):580–585.
   PubMed Web of Science ®Google Scholar
• King-Yin Lam A, Ong K, Ho YH. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Dis Colon Rectum. 2006;49(9):1275–1283.
   PubMed Web of Science ®Google Scholar
• Lam AK, Ho YH. Primary squamous cell carcinoma of the rectum in a patient on immunosuppressive therapy. Pathology. 2006;38(1):74–76.
   PubMed Web of Science ®Google Scholar
• Alvarado MD, Jensen EH, Yeatman TJ. The potential role of gene expression in the management of primary and metastatic colorectal cancer. Cancer Control. 2006;13(1):27–31.
   PubMedGoogle Scholar
• An HJ, Ryu M, Jeong HJ, et al. Higd-1a regulates the proliferation of pancreatic cancer cells through a pERK/p27(KIP1)/pRB pathway. Cancer Lett. 2019;461:78–89.
   PubMed Web of Science ®Google Scholar
• Zong WX, Rabinowitz JD, White E. Mitochondria and cancer. Mol Cell. 2016;61(5):667–676.
   PubMed Web of Science ®Google Scholar
• Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016;166(3):555–566.
   PubMed Web of Science ®Google Scholar
• Alcorta DA, Xiong Y, Phelps D, et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A. 1996;93(24):13742–13747.
   PubMed Web of Science ®Google Scholar
• Weinberg F, Hamanaka R, Wheaton WW, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A. 2010;107(19):8788–8793.
   PubMed Web of Science ®Google Scholar
• Tan AS, Baty JW, Dong LF, et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab. 2015;21(1):81–94.
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5):e1600200.
   PubMed Web of Science ®Google Scholar
• Ni HM, Williams JA, Ding WX. Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 2015;4:6–13.
   PubMed Web of Science ®Google Scholar
• Wang J, Cao Y, Chen Y, et al. Pancreatic beta cells lack a low glucose and O2-inducible mitochondrial protein that augments cell survival. Proc Natl Acad Sci U S A. 2006;103(28):10636–10641.
   PubMed Web of Science ®Google Scholar
• Denko N, Schindler C, Koong A, et al. Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res. 2000;6(2):480–487.
   PubMed Web of Science ®Google Scholar
• An HJ, Shin H, Jo SG, et al. The survival effect of mitochondrial Higd-1a is associated with suppression of cytochrome C release and prevention of caspase activation. Biochim Biophys Acta. 2011;1813(12):2088–2098.
   PubMed Web of Science ®Google Scholar
• Vukotic M, Oeljeklaus S, Wiese S, et al. Rcf1 mediates cytochrome oxidase assembly and respirasome formation, revealing heterogeneity of the enzyme complex. Cell Metab. 2012;15(3):336–347.
   PubMed Web of Science ®Google Scholar
• Hayashi H, Nakagami H, Takeichi M, et al. HIG1, a novel regulator of mitochondrial γ-secretase, maintains normal mitochondrial function. FASEB J. 2012;26(6):2306–2317.
   PubMed Web of Science ®Google Scholar
• An HJ, Cho G, Lee JO, et al. Higd-1a interacts with Opa1 and is required for the morphological and functional integrity of mitochondria. Proc Natl Acad Sci U S A. 2013;110(32):13014–13019.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Asano Y, Shintani Y, et al. Higd1a is a positive regulator of cytochrome c oxidase. Proc Natl Acad Sci U S A. 2015;112(5):1553–1558.
   PubMed Web of Science ®Google Scholar
• Ameri K, Jahangiri A, Rajah AM, et al. HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth. Cell Rep. 2015;10(6):891–899.
   PubMed Web of Science ®Google Scholar
• Barger CJ, Branick C, Chee L, et al. Pan-cancer analyses reveal genomic features of FOXM1 overexpression in cancer. Cancers (Basel). 2019;11(2):2.
   Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Jiang L, Shen J, Zhang N, et al. Association of RGS20 expression with the progression and prognosis of renal cell carcinoma. Oncol Lett. 2021;22(3):643.
   PubMed Web of Science ®Google Scholar
• Xu X, Zheng S. MiR-887-3p negatively regulates STARD13 and promotes pancreatic cancer progression. Cancer Manag Res. 2020;12:6137–6147.
   PubMed Web of Science ®Google Scholar
• Yang J, Liu Y, He A, et al. HSA-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B. Oncotarget. 2017;8(40):68721–68729.
   PubMedGoogle Scholar
• Ruan WD, Wang P, Feng S, et al. MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells. Onco Targets Ther. 2016;9:303–313.
   PubMed Web of Science ®Google Scholar
• Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol. 2018;13:395–412.
   PubMed Web of Science ®Google Scholar
• Hauptman N, Boštjančič E, Žlajpah M, et al. Bioinformatics analysis reveals most prominent gene candidates to distinguish colorectal adenoma from adenocarcinoma. Biomed Res Int. 2018;2018:9416515.
   PubMed Web of Science ®Google Scholar
• Cao H, Xu E, Liu H, et al. Epithelial-mesenchymal transition in colorectal cancer metastasis: a system review. Pathol Res Pract. 2015;211(8):557–569.
   PubMed Web of Science ®Google Scholar
• Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–767.
   PubMed Web of Science ®Google Scholar
• Ioannou M, Paraskeva E, Baxevanidou K, et al. HIF-1α in colorectal carcinoma: review of the literature. J buon. 2015;20(3):680–689.
   PubMed Web of Science ®Google Scholar